Sanofi chooses Swansea as UKs pioneer Diabetes Centre of Excellence
Category: #health  By Saipriya Iyer  Date: 2018-05-25
  • share
  • Twitter
  • Facebook
  • LinkedIn

Sanofi chooses Swansea as UKs pioneer Diabetes Centre of Excellence

Sanofi S.A., a French pharma company, has joined hands with the UK-based Swansea University Medical School, opting for the organization to be the country’s first Diabetes Centre of Excellence. Sanofi has chosen the JCRF (Joint Clinical Research Facility) of the Medical school along with Cymru, Swansea’s diabetes research establishment.

Reportedly, UK’s reputed medical school had already worked with the pharma giant on several critical projects. However, it has been chosen by Sanofi after JCRF repeatedly exhibited its capability to provide excellent services to its customers. For the record, JCRF is the combined entity of Swansea University Medical School & Abertawe Bro Morgannwg University Health Board.

Prof. Steve Bain, the Clinical Lead for the Diabetes Research Unit at Cymru, has stated that the university is looking forward to working on the drug product portfolio in collaboration with Sanofi S.A. Professor Keith Lloyd, the Dean of Swansea, has also reportedly emphasized that the high-quality R&D activities carried out in the field of diabetes at Swansea University will help in tackling the current healthcare issues related to diabetes.

As per Victoria DiBiaso, Global Head of Clinical Operations Strategy & Collaboration at Sanofi, the goal of the collaboration of Sanofi & Swansea is aimed at utilizing JCRF’s knowledge related to diabetes research in clinical tests conducted by Sanofi. She further added that establishing liaisons with reputed research organizations working on diabetes will assist the firm in carrying out medical trials effectively. Experts familiar with the matter claim that the collaboration may prove to be highly beneficial for diabetic patients in the near future.

Sanofi joint venture with the based Swansea University Medical School is speculated to address the social & healthcare requirements of diabetics and explore key areas in diabetes research. Analysts have projected that the partnership will help in fulfilling the unmet medical requirements of patients in addition to supporting the economic growth in Wales.



About Author

Saipriya Iyer

Email: [email protected]   

Saipriya Iyer

Saipriya Iyer develops content for Market Size Forecasters, Algosonline, and myriad other platforms. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her bel...

Read More

More News By Saipriya Iyer

Tetra Pak announces target to reach net-zero GHG emissions by 2030
Tetra Pak announces target to reach net-zero GHG emissions by 2030
By Saipriya Iyer

Tetra Pak, a food processing and packaging solutions provider, has recently announced its target to reach net-zero GHG (greenhouse gas) emissions in its operations by 2030.

The targ...

DTE Energy pledges to reach net-zero emissions of GHG by 2050
DTE Energy pledges to reach net-zero emissions of GHG by 2050
By Saipriya Iyer

DTE Energy has reportedly pledged to reach the net-zero GHG (greenhouse gas) emissions by 2050. This can be ensured through various actions involving customers, suppliers, and its infrastructure, that align with the lo...

Researchers investigate a novel treatment for Childhood Alzheimer’s
Researchers investigate a novel treatment for Childhood Alzheimer’s
By Saipriya Iyer

Researchers at the Lundquist Institute have reportedly collaborated with the Cure Sanfilippo Foundation on a new clinical trial to investigate if repurposing an anti-inflammatory drug could provide relief to children t...